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Abstract
Objective:  Urinary  tract  infection  (UTI)  is  the  most  common  bacterial  infection  in  childhood.
UTI may  be  the  sentinel  event  for  underlying  renal  abnormality.  There  are  still  many  contro-
versies regarding  proper  management  of  UTI.  In  this  review  article,  the  authors  discuss  recent
recommendations  for  the  diagnosis,  treatment,  prophylaxis,  and  imaging  of  UTI  in  childhood
based on  evidence,  and  when  this  is  lacking,  based  on  expert  consensus.
Sources:  Data  were  obtained  after  a  review  of  the  literature  and  a  search  of  Pubmed,  Embase,
Scopus, and  Scielo.
Summary  of  the  ﬁndings:  In  the  ﬁrst  year  of  life,  UTIs  are  more  common  in  boys  (3.7%)  than
in girls  (2%).  Signs  and  symptoms  of  UTI  are  very  nonspeciﬁc,  especially  in  neonates  and  during
childhood; in  many  cases,  fever  is  the  only  symptom.
Conclusions:  Clinical  history  and  physical  examination  may  suggest  UTI,  but  conﬁrmation  should
be made  by  urine  culture,  which  must  be  performed  before  any  antimicrobial  agent  is  given.
During childhood,  the  proper  collection  of  urine  is  essential  to  avoid  false-positive  results.
Prompt diagnosis  and  initiation  of  treatment  is  important  to  prevent  long-term  renal  scar-
ring. Febrile  infants  with  UTIs  should  undergo  renal  and  bladder  ultrasonography.  Intravenous
antibacterial  agents  are  recommended  for  neonates  and  young  infants.  The  authors  also  advise
exclusion  of  obstructive  uropathies  as  soon  as  possible  and  later  vesicoureteral  reﬂux,  if  indi-
cated. Prophylaxis  should  be  considered  for  cases  of  high  susceptibility  to  UTI  and  high  risk  of
renal damage.
©  2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
 Please cite this article as: Simões e Silva AC, Oliveira EA. Update on the approach of urinary tract infection in childhood. J Pediatr (Rio
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Atualizac¸ão  da  abordagem  de  infecc¸ão do  trato  urinário  na  infância
Resumo
Objetivo:  A  infecc¸ão  do  trato  urinário  (ITU)  é  a  infecc¸ão  bacteriana  mais  comum  na  infância.  A
ITU pode  ser  o  evento  sentinela  para  alterac¸ão  renal  subjacente.  Ainda  há  muitas  controvérsias
com relac¸ão  ao  tratamento  adequado  da  ITU.  Neste  artigo  de  revisão,  discutimos  as  últimas
recomendac¸ões para  diagnóstico,  tratamento,  proﬁlaxia  e  imagiologia  da  ITU  na  infância,  com
base em  comprovac¸ão  e,  na  sua  ausência,  com  base  no  consenso  de  especialistas.
Fonte  de  dados: Os  dados  foram  coletados  após  uma  revisão  da  literatura  e  pesquisa  no
Pubmed, Embase,  Scopus  e  Scielo.
Resumo  dos  dados: No  primeiro  ano  de  vida,  as  ITUs  são  mais  comuns  em  meninos  (3,7%)  que  em
meninas (2%).  Os  sinais  e  sintomas  da  ITU  são  muito  inespecíﬁcos,  principalmente  em  neonatos
e durante  a  infância,  sendo  a  febre  o  único  sintoma  em  muitos  casos.
Conclusões:  O  histórico  clínico  e  exame  físico  podem  sugerir  ITU,  porém  a  conﬁrmac¸ão  deve
ser feita  por  urocultura.  Antes  da  administrac¸ão  de  qualquer  agente  antimicrobiano,  deve  ser
feita coleta  de  urina.  Durante  a  infância,  a  coleta  de  urina  adequada  é  essencial  para  evitar
resultados  falso-positivos.  O  diagnóstico  e  início  do  tratamento  imediatos  são  importantes  na
prevenc¸ão de  cicatriz  renal  de  longo  prazo.  Neonatos  febris  com  ITUs  devem  ser  submetidos
a ultrassonograﬁa  renal  e  da  bexiga,  Agentes  antibacterianos  intravenosos  são  recomendados
para neonatos  e  neonatos  jovens.  Recomendamos  também  a  exclusão  de  uropatias  obstrutivas
o mais  rápido  possível  e  posterior  reﬂuxo  vesico-ureteral,  caso  indicado.  A  proﬁlaxia  deve  ser
considerada  em  casos  de  elevada  susceptibilidade  a  ITU  e  risco  elevado  de  danos  renais.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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Urinary  tract  infection  (UTI)  is  the  most  common  bacterial
infection  in  childhood,1--4 and  up  to  30%  of  infants  and  chil-
dren  experience  recurrent  infections  during  the  ﬁrst  6--12
months  after  initial  UTI.5,6 UTIs  may  be  the  sentinel  event
for  underlying  renal  abnormality,  although  normal  anatomy
is  more  common.7 Prompt  diagnosis  and  initiation  of  treat-
ment  is  important  in  preventing  long-term  renal  scarring.
However,  increasing  antibiotic  resistance  may  delay  initia-
tion  of  appropriate  therapy.
In  young  infants,  symptoms  of  UTI  differ  from  those  in
older  children.8,9 The  prevalence  of  UTI  is  higher  in  infants
than  in  older  children,  with  a  male  predominance.7,10,11 Most
infections  are  caused  by  Escherichia  coli, although,  in  the
ﬁrst  year  of  life,  Klebsiella  pneumoniae, Enterobacter  spp.,
Enterococcus  spp.,  and  Pseudomonas  spp.  are  more  frequent
than  later  in  life,  and  there  is  a  higher  risk  of  urosepsis
compared  with  adulthood.7,8,10--12
In  30%  of  children  with  congenital  anomalies  of  the  kid-
ney  and  urinary  tract  (CAKUT),  UTI  can  be  the  ﬁrst  sign.13 If
pediatricians  fail  to  identify  patients  at  risk,  the  upper  uri-
nary  tract  may  be  damaged.  Up  to  85%  of  infants  and  children
with  febrile  UTI  may  have  visible  alterations  on  technetium
Tc  99-labeled  dimercaptosuccinic  acid  (DMSA)  scanning.  Of
these  children,  10--40%  have  permanent  renal  scarring,14--16
which  may  lead  to  poor  renal  growth,  recurrent  pyelonephri-
tis,  impaired  glomerular  function,  early  hypertension,  and,
eventually,  end-stage  renal  disease.14,15,17--20
Therefore,  identifying  children  at  risk  of  renal  parenchy-
mal  damage  and  follow-up  imaging  after  UTI  is  a  very
difﬁcult  task.  Furthermore,  the  use  of  antibiotic  prophylaxis
h
c
olso  remains  controversial.  In  this  review  article,  the  authors
iscuss  recent  recommendations  for  the  diagnosis,  treat-
ent,  prophylaxis,  and  imaging  of  UTI  in  childhood  based  on
vidence,  and  when  this  is  lacking,  based  on  expert  consen-
us.
rinary tract infection in pediatrics: general
onsiderations
he  incidence  of  UTIs  depends  on  age  and  sex.  In  the  ﬁrst
ear  of  life,  UTIs  are  more  common  in  boys  (3.7%)  than  in
irls  (2%).  This  is  even  more  pronounced  in  febrile  infants
n  the  ﬁrst  2  months  of  life,  with  an  incidence  of  5%  in  girls
nd  20.3%  in  uncircumcised  boys,  as  demonstrated  in  one
rospective  study  including  over  1000  patients  using  urine
pecimens  obtained  by  catheterization.10 Later,  the  inci-
ence  changes,  and  approximately  3%  of  prepubertal  girls
nd  1%  of  prepubertal  boys  are  diagnosed  with  UTI.10,11,13
The  ﬁrst  step  for  the  diagnosis  of  UTI  is  medical  his-
ory.  Indeed,  the  patient’s  history  normally  allows  for  the
dentiﬁcation  of  the  site,  episode,  symptoms,  and  compli-
ating  factors.7,9,11,12 This  includes  questions  on  primary  or
econdary  infection,  febrile  or  non-febrile  UTIs;  history  of
alformations  of  the  urinary  tract  (e.g.,  pre-  or  postnatal
ltrasound  [US]  screening);  previous  surgeries;  drinking  and
oiding  habits;  family  history;  whether  there  is  constipation
r  presence  of  lower  urinary  tract  symptoms;  and  sexual
istory  in  adolescents.
Signs  and  symptoms  of  UTI  are  very  nonspeciﬁc,  espe-
ially  in  neonates  and  during  childhood.  Fever  may  be  the
nly  symptom  of  UTI,  especially  in  young  children.1,21--23
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ewborns  with  pyelonephritis  or  urosepsis  can  present  non-
peciﬁc  signs  and  symptoms,  sometimes  without  fever.24,25
eptic  shock  is  unusual,  even  with  high  fever,26 unless
bstruction  is  present  or  the  patient  is  otherwise  com-
romised.  In  older  children,  lower  urinary  tract  symptoms
nclude  dysuria,  frequency,  urgency,  malodorous  urine,
ncontinence,  hematuria,  and  suprapubic  pain;  for  the  upper
rinary  tract,  fever  and  ﬂank  pain.  A  complete  pediatric
hysical  examination  is  always  required  to  exclude  any  other
ource  of  fever.  Conversely,  if  the  fever  has  no  apparent
ause,  UTI  should  always  be  discarded.3,4,11 Physical  exami-
ation  should  search  for  signs  of  constipation,  palpable  and
ainful  kidney,  palpable  bladder  (stigmata  of  spina  biﬁda
r  sacral  agenesis  spine  and  feet),  genital  disorders  (phi-
osis,  labial  adhesion,  urethral  meatal  stenosis,  abnormal
rogenital  conﬂuence,  cloacal  malformations,  vulvitis,  and
pididymo-orchitis),  and  measure  temperature.
According  to  site  of  predominant  alteration,  UTI  may
e  classiﬁed  as  cystitis  or  pyelonephritis.  Cystitis  is  inﬂam-
ation  of  the  urinary  bladder  mucosa,  with  symptoms  of
ower  urinary  tract  infection.7,8,12 However,  in  newborns  and
nfants,  these  symptoms  are  rarely  diagnosed  accurately.7
n  pyelonephritis,  the  bacteria  have  ascended  through  the
pper  urinary  tract  to  the  kidneys,  causing  inﬂammation
hat  could  lead  to  renal  damage  or  deterioration  of  pre-
xisting  scars.  In  children  with  dilating  vesicoureteral  reﬂux
VUR),  there  is  a  strong  correlation  between  febrile  UTI
ecurrence  and  renal  scarring.27 Apart  from  the  risk  of
eveloping  renal  damage,  every  symptomatic  UTI  causes
iscomfort  and  distress,  which  is  enough  to  justify  the
ffort  to  reduce  recurrences.28 It  should  be  also  mentioned
hat  the  introduction  of  antenatal  screening  for  malfor-
ations  with  ultrasonography  has  made  the  detection  of
rinary  tract  abnormalities  possible  before  any  infections
ave  occurred.29--31
E.  coli  is  the  predominant  pathogen  in  childhood  UTI,
ound  in  90%  of  girls  and  in  80%  of  boys  at  the  ﬁrst  episode
f  UTI.2,3,8,12,32 An  important  factor  for  the  predominance  of
.  coli  is  the  ability  of  this  pathogen  to  attach  to  the  uri-
ary  tract  endothelium.  The  preputial  area  is  colonized  by
on-E.  coli  Gram-negative  bacteria  in  uncircumcised  boys,
ence  the  different  bacterial  spectrum  in  male  UTI.  In
ecurrent  infections,  the  proportion  of  non-E. coli  is  higher
han  Klebsiella  spp.,  enterococci,  Enterobacteriaceae,  and
roteus  spp.  If  urine  culture  yields  unusual  bacteria,  follow-
p  investigations  will  often  disclose  CAKUT.8,31,32 Atypical
pecies  are  also  more  commonly  observed  in  infections  sec-
ndary  to  invasive  procedures  or  indwelling  catheters.  UTI
ollowing  antibiotic  treatment  for  other  infections  is  also
ore  frequently  caused  by  non-E. coli  species,  as  repeated
ntibiotic  treatment  has  the  potential  to  select  atypical
athogens.8,31--33
rinary tract infection in infancy: speciﬁc
spects
s  already  mentioned,  the  clinical  presentation  of  UTI  is
eterogeneous,  varying  according  to  age  group  and  location
f  the  infection.34 Other  factors  may  also  inﬂuence  clinical
anifestations  of  UTI,  such  as  nutritional  status,  presence
f  abnormalities  of  the  urinary  tract,  number  of  previous
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nfections,  and  the  time  interval  from  the  last  episode.  The
linical  picture  may  vary  from  isolated  fever  or  changes  in
rinary  habits  to  acute  pyelonephritis,  which  may  lead  to
rosepsis,  especially  in  infants.35
In  newborns,  UTI  may  manifests  as  sepsis,  predominantly
ith  nonspeciﬁc  signs  and  symptoms,  including  insufﬁcient
eight  gain,  anorexia,  vomiting,  poor  sucking,  irritability,
ethargy,  convulsions,  and  hypothermia.  It  may  also  present
ith  less  acute  symptoms,  such  as  food  refusal,  occasional
omiting,  pallor,  and  jaundice.36 The  American  Academy
f  Pediatrics  recommends  that  infants  with  elevated  direct
ilirubin  levels  should  be  screened  for  UTIs.  However,  those
ith  elevated  unconjugated  bilirubin  levels  should  not  be
xcluded,  especially  if  other  concerning  clinical  features  are
resent.37 As  with  most  infections,  in  this  age  group,  there
s  high  probability  of  bacteremia,  suggesting  hematogenous
acterial  spread.  There  is  a  high  rate  of  mortality  (around
0%),  and  many  of  these  deaths  are  due  to  the  spread
f  infection  to  another  sites,  leading  to  meningitis,  for
nstance.38
In  infants,  fever  is  the  main  symptom,  and  often  the  only
ign  of  infection.  Rarely,  there  are  signs  or  symptoms  related
o  the  urinary  tract,  such  as  urinary  frequency,  dysuria,
oul-smelling  urine,  and  back  pain.  However,  high  tem-
erature  associated  with  nonspeciﬁc  manifestations,  such
s  appetite  loss,  vomiting,  abdominal  pain,  dehydration,
nd  poor  weight  gain  are  commonly  found  in  infants  with
TI.34--36
The  physical  examination  should  be  complete,  covering
utritional  aspects,  growth,  and  psychomotor  development.
areful  palpation  of  abdominal  ﬂanks  may  reveal  increased
enal  volume  (a  symptom  of  severe  hydronephrosis  or  cys-
ic  kidneys,  for  example).  The  persistence  of  palpable
ladder  after  micturition  suggests  obstructive  process  or
ower  urinary  tract  dysfunction.  In  infants,  the  lumbar  per-
ussion  may  rarely  show  strong  painful  reaction  (positive
iordano).34--36 Particularly  in  this  age  group,  the  observa-
ion  of  the  urine  stream,  during  the  physical  examination,
s  helpful.  A  weak  or  dripping  stream  arises  the  possibility
f  low  urinary  tract  obstruction,  such  as  posterior  urethral
alves  in  boys.39
A  thorough  examination  of  the  external  genitalia  is
andatory  in  neonates  and  infants.  It  is  essential  to  eval-
ate  anatomical  conformation,  speciﬁcally  the  appearance
nd  location  of  the  urethral  meatus  and  narrowing  of  the
oreskin,  which  prevent  the  exposure  of  the  urethral  meatus
n  boys.  It  is  important  to  rule  out  the  presence  of  vulvo-
aginitis  or  balanoposthitis  that  can  lead  to  a  false-positive
aboratory  diagnosis  of  UTI.  Constant  and/or  uncontrollable
oss  of  urine,  especially  when  observed  during  the  physical
xamination,  suggests  ectopic  ureter.  A  careful  examina-
ion  of  spine  column  is  also  indispensable,  searching  for
bnormalities  on  spinal  curvature/symmetry  and  evidence
f  spina  biﬁda  occulta  or  pilonidal  sinus  hidden  by  creases
r  dimples.11
The  diagnosis  of  UTI  in  infants  is  based  on  clinical  and
aboratorial  ﬁndings,  including  detailed  clinical  history  and
hysical  examination.  In  the  anamnesis,  in  addition  to  spe-
iﬁc  symptoms  of  UTI,  it  is  important  to  inquire  about  bowel
abits  (constipation  and  fecal  leaks),  characteristics  of  the
rinary  stream,  and  general  symptoms  associated  (fever,
omiting,  diarrhea,  stunted  weight  gain).  History  of  the
S5
Table  1  Criteria  for  diagnosing  urinary  tract  infection  (UTI)
in children.
Method  of  urine
sampling
UTI  diagnose
Suprapubic  bladder
aspiration
Any  number  of  CFU  per  mL
(at  least  10  identical  colonies)
Bladder
catheterization
1000--50,000  CFU/mL
Plastic  bag  >104 CFU/mL  with  symptoms
>105 CFU/mL  without
symptoms
Source: Adapted from: Stein et al. European Urology 2015.11
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pregnancy  should  also  be  investigated,  including  prenatal
sonographic  ﬁndings,  such  as  fetal  hydronephrosis  and  other
clues  for  CAKUT,  neural  tube  disorders,  and  amniotic  ﬂuid
volume.  The  family  history  should  include  questions  about
CAKUT  in  relatives,  such  as  VUR,  obstructions  of  the  urinary
tract,  and  cystic  renal  diseases.
UTI in childhood: practical approach
Diagnosis
Diagnosis  and  management  of  UTI  is  one  of  the  most----if
not  the  most----controversial  areas  of  pediatrics.  One  fac-
tor  contributing  to  the  current  situation  is  the  unexpected
difﬁculty  in  diagnosing  UTI  in  infants.  Substantial  over-  and
under-diagnosing  can  result  from  practical  difﬁculties  in  at
least  three  areas,  including  problems  with  urine  sample  col-
lection,  issues  in  interpreting  bacterial  counts  correctly,
and  misdiagnosis  between  infantile  asymptomatic  bacteri-
uria  and  true  symptomatic  febrile  UTI.40
Clinical  history  and  physical  examination  may  suggest  the
diagnosis  of  UTI,  but  conﬁrmation  should  be  made  by  urine
culture,  which  will  show  the  proliferation  of  microorganisms
in  the  urinary  tract.41 Therefore,  before  any  antimicrobial
agent  is  given,  urine  culture  must  be  performed.11 Dur-
ing  infancy,  the  proper  collection  of  urine  is  essential  to
avoid  false-positive  results;  it  should  be  done  after  clean-
ing  the  genital  area  with  water  and  soap  without  antiseptic
agents.40 In  newborns,  infants,  and  non-toilet-trained  chil-
dren,  there  are  four  main  methods  for  obtaining  urine,  with
varying  contamination  rates  and  invasiveness.11 A  plastic
bag  attached  to  the  cleaned  genitalia  is  the  technique  most
often  used  in  daily  practice.42 Although  a  culture-negative
urine  bag  sample  is  reliable,  this  technique  has  high  rate  of
false-positive  cultures  due  to  contamination  by  periurethral
ﬂora.43 McGillivray  et  al. 44 compared  the  validity  of  the  uri-
nalysis  on  clean-voided  bag  versus  catheter  urine  specimens
using  the  catheter  culture  as  the  gold  standard  in  a  cross-
sectional  study  of  303  non  toilet-trained  children  under  age
3  years  at  risk  of  UTI  who  presented  to  a  children’s  hospi-
tal  emergency  department.  Bag  dipstick  was  more  sensitive
than  catheter  dipstick  for  the  entire  study  sample:  0.85
versus  0.71,  respectively.  Conversely,  speciﬁcity  was  con-
sistently  lower  for  the  bag  specimens  than  for  the  catheter
specimens:  0.62  versus  0.97,  respectively.
For  clean-catch  urine  collection,  the  infant  is  placed  in
the  lap  of  a  parent  or  nurse  holding  a  sterile  foil  bowl  under-
neath  the  infant’s  genitalia.  There  is  a  good  correlation
between  results  of  urine  culture  obtained  by  this  method
and  by  suprapubic  bladder  aspiration.45 However,  a  study
with  120  infants  and  children  observed  a  25%  contamina-
tion  rate  with  samples  from  clear-voided  urine  compared  to
samples  from  suprapubic  aspiration.46
Suprapubic  bladder  aspiration  (SPA)  is  the  most  sensi-
tive  method  for  obtaining  an  uncontaminated  urine  sample.
When  urine  is  collected  by  suprapubic  aspiration,  a  method
that  bypasses  the  urethra,  any  colony  count  is  consid-
ered  to  represent  signiﬁcant  bacteriuria.  All  other  methods
of  urine  collection  (mid-stream  clean  catch,  catheteriza-
tion,  and  bag  collections)  require  passage  of  urine  through
the  urethra.  SPA  has  been  considered  the  gold  standard
U
i
o
iCFU, colony-forming units.
or  obtaining  urine  that  is  uncontaminated  by  perineal
ora.  Variable  success  rates  for  obtaining  urine  have  been
eported  (23--90%),37 increasing  when  ultrasonography  guid-
nce  is  used.47 The  technique  has  limited  risks,  but  technical
xpertise  and  experience  are  required,  and  many  parents
nd  physicians  perceive  the  procedure  as  unacceptably  inva-
ive.  However,  there  may  be  no  acceptable  alternative  to
PA  for  boys  with  severe  phimosis,  girls  with  tight  labial
dhesions,  presence  of  external  genital  infection,  or  pres-
nce  of  genital  complex  abnormalities.
Bladder  catheterization  may  be  an  alternative  to  SPA,
lthough  the  rates  of  contamination  are  higher.  Urine
btained  through  catheterization  for  culture  has  a  sensitiv-
ty  of  95%  and  a  speciﬁcity  of  99%  when  compared  with  that
btained  through  SPA.48
In  order  to  choose  a  particular  method,  it  is  important  to
onsider  the  clinical  condition  of  the  patient,  the  experience
f  healthcare  team,  and  the  resources  of  the  pediatric  or
rgency  center  facilities.
The  deﬁnitive  diagnosis  of  UTI  in  infants  is  a  continuous
hallenge  for  physicians,  and  a  judicious  interpretation  of
ests  results  is  mandatory.  In  urine  analysis,  dipstick  tests
or  nitrite,  leukocyte  esterase,  protein,  glucose,  and  blood
s  very  useful.49 A  dipstick  test  that  is  positive  for  leuko-
yte  esterase  and  nitrite  is  highly  sensitive  for  the  diagnose
f  UTI.  A  test  that  is  negative  for  leukocyte  esterase  and
itrite  is  highly  speciﬁc  for  discarding  UTI.49 In  urine  culture,
he  classical  deﬁnition  of  >105 CFU/ml  of  voided  urine  is  still
sed  to  deﬁne  signiﬁcant  UTI.  It  is  well  established  that  dif-
erent  cut-off  levels  are  used  for  bag  cultures,  SPAs,  and
ultures  from  catheterized  samples  (see  Table  1,  adapted
rom  Stein  et  al.).11 The  recent  American  Academy  of  Pedi-
trics  (AAP)  Guidelines  on  UTI  suggest  that  the  diagnosis
hould  be  based  on  the  presence  of  both  pyuria  and  at  least
0,000  CFU/mL  in  an  SPA  sample.  Mixed  cultures  indicate
ontamination.37
In  infants,  C-reactive  protein  and  blood  cell  counts  should
e  obtained  for  monitoring  ill  patients  with  febrile  UTI.  In
ddition,  in  a  severely  ill  child,  renal  function  and  blood
ultures  should  also  be  taken.  For  infants  with  febrile  UTI,
S  imaging  of  the  urinary  tract  can  be  very  useful  dur-
ng  the  acute  phase,  for  instance,  to  promptly  identify  an
bstructive  uropathy.  Early  US  examination  is  also  indicated
n  children  with  suspected  urosepsis,  palpable  abdominal
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masses,  hematuria,  and  for  patients  without  response  to  the
standard  management.11,37
Treatment
In  febrile  children  with  signs  of  UTI  (clinical  signs,  positive
dipstick,  and/or  positive  microscopy),  antibiotic  treatment
should  be  initiated  as  soon  as  possible  to  eradicate  the
infection,  prevent  bacteremia,  improve  clinical  outcome,
diminish  the  likelihood  of  renal  involvement  during  the
acute  phase  of  infection,  and  reduce  the  risk  of  renal  scar-
ring.  As  previously  stated,  before  any  antibiotic  therapy  is
started,  a  urine  specimen  should  be  obtained  for  urinalysis
and  urine  culture.50
Proper  treatment  includes  the  relief  of  symptoms,  eradi-
cation  of  the  infectious  agent,  and  identiﬁcation  of  patients
at  high  risk  of  developing  lesions  in  the  renal  parenchyma.
For  relief  of  symptoms,  analgesic  and  antipyretic  drugs
should  be  prescribed  at  usual  doses.  In  neonates  and  young
infants,  physicians  should  be  watchful  for  early  detection  of
signs  or  symptoms  of  urosepsis,  septic  shock,  or  hypovolemic
status.  For  patients  with  low  oral  intake  or  with  dehydra-
tion,  rehydration  must  be  readily  provided,  if  necessary,  via
parenteral  route.11,43
Empiric  therapy  for  neonates  and  young  infants  with  UTI
and  sepsis  are  similar  because  of  common  etiology.  There-
fore,  as  a  result  of  the  high  incidence  of  urosepsis  and  severe
pyelonephritis  in  newborns  and  infants  <3  months  of  age,
parenteral  antibiotic  therapy  is  always  recommended.  Oth-
erwise,  when  choosing  between  oral  and  parenteral  therapy,
some  factors  should  be  considered:  patient  age,  severity
of  illness,  refusal  of  oral  intake,  vomiting,  noncompliance
with  oral  medication,  and  potential  complicated  febrile
UTI  (for  instance,  severe  urinary  tract  dilatation).7,11,37,51 A
multicenter  randomized  controlled  trial  by  Montini  et  al.52
demonstrated  that  oral  therapy  was  as  effective  as  intra-
venous  therapy  followed  by  oral  therapy  for  managing  the
ﬁrst  UTI  episode.
Traditionally,  intravenous  antibiotics  are  started  once
appropriate  cultures  are  obtained.  A  combined  treatment
with  ampicillin  and  an  aminoglycoside  or  a  third-
generation  cephalosporin  usually  achieves  excellent  ther-
apeutic  results.53 The  choice  of  agent  is  also  based  on
local  antimicrobial  sensitivity  patterns  and  can  be  later
adjusted,  according  to  sensitivity  testing  of  the  isolated
pathogen.  Tables  2  and  3  present  a  scheme  of  frequently
used  parenteral  and  oral  agents,  respectively,  for  the  treat-
ment  of  UTI  in  infants.  Most  infections  are  caused  by
E.  coli, although  during  the  ﬁrst  year  of  life,  K.  pneumoniae,
Enterobacter  spp.,  Enterococcus  spp.,  and  Pseudomonas
Table  2  Options  of  antibacterial  agents  via  parentheral  for
the treatment  of  urinary  tract  infection.
Agent  Daily  dosage/kg  Application  Number  of
doses/day
Cephtriaxone  50  TO  100  mg  IV  ou  IM  1  to  2
Gentamicin  7.5  mg  IV  ou  IM  3
Amikacin  15  mg  IV  ou  IM  1  to  2
IV, intravenous; IM, intramuscular.
Table  3  Options  of  antibacterial  agents  via  oral  adminis-
tration for  the  treatment  of  urinary  tract  infection.
Agent  Daily
dosage/kg
Number  of
doses  per  day
Sulfamethoxazole  +
trimethoprim
40 mg  +  8  mg 2
Cephadroxil  30  to  50  mg  2
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wCephalexin  50  to  100  mg  4
Amoxicilin  +  clavulanate  40  mg  +  5.7  mg  2
pp.  are  more  frequent  than  later  in  life.  In  infants  with  uri-
ary  tract  abnormalities,  there  is  also  a  higher  prevalence
f  ‘‘atypical’’  bacteria.36
Improvement  of  the  general  clinical  condition  and
he  reduction  of  fever  within  48--72  h  are  indicative  of
ood  response  to  treatment  with  antibiotics.  Conversely,
n  patients  with  prolonged  fever  and  failing  recovery,
reatment-resistant  uropathogens  and  the  presence  of  con-
enital  uropathy  or  acute  urinary  obstruction  should  be
onsidered;  an  US  examination  is  highly  advisable.  Tem-
orary  urinary  diversion  may  be  required  in  infants  with
bstructive  uropathy  or  with  severely  dilated  urinary  tract,
n  case  of  non-response  to  antibiotic  therapy  and/or  wors-
ning  on  clinical  status.11
Very  few  studies  have  evaluated  the  duration  of  treat-
ent  and  the  transition  from  parenteral  to  oral  therapy
n  infants.  In  the  premature  infant,  the  bioavailability  of
ost  antibiotics  is  not  known;  therefore,  intravenous  ther-
py  is  typically  preferred.  Documentation  of  negative  blood
nd  cerebral  spinal  ﬂuid  cultures  in  both  premature  and
oung  infants  is  advisable.7 In  older  infants,  Benador  et  al.
4 observed  that  the  risk  of  renal  scarring  was  not  different
etween  infants  that  received  three  days  of  parental  ther-
py  followed  by  seven  days  of  oral  therapy  when  compared
ith  10  days  of  oral  therapy.  Thus,  in  older  and  more  mature
nfants,  three  to  four  days  of  parental  therapy  followed  by
ransition  to  oral  medications  to  complete  a 7-  to  14-day
ourse  of  treatment  can  be  used.  If  outpatient  management
nd  oral  therapy  are  chosen,  close  surveillance  and  medi-
al  supervision  are  critical  in  the  initial  phase  of  therapy;
reatment  should  be  adjusted  when  necessary.
reventing  UTI  recurrence:  prophylaxis
pproximately  20%  of  children  who  have  had  one  UTI
xperience  a  symptomatic  recurrence.55 Preventing  UTI
ecurrence  would  avoid  further  episodes  of  illness,  dis-
omfort,  and  family  stress.26 There  are  many  studies  on
rophylaxis  with  contradictory  results  and  divergent  conclu-
ions,  but  only  a  few  of  them  are  properly  randomized  and
ontrolled.  Evidence  regarding  the  efﬁcacy  of  prophylactic
herapy  to  prevent  recurrences  after  the  ﬁrst  episode  of  UTI
s  lacking  for  the  infant  population.56,57
A  long-term  follow-up  of  71  infants  with  UTI  showed
 recurrence  rate  of  28%.  Most  of  the  episodes  of
ecurrence  (65%)  occurred  in  the  ﬁrst  six  months  after
he  initial  UTI,  and  75%  occurred  in  patients  without  any
enal  abnormalities.25 A  recent  study  compared  infants
ith  VUR  and  recurrent  UTI  (mean  age:  3.2  months)  and
S7
Table  4  Options  of  antibacterial  prophylaxis  for  urinary
tract  infection  recurrences.
Agent  Prophylactic  dose
per  day,  mg/kg
Limitations
Nitrofurantoin  1  to  2 Not
recommended  <  3
months  of  age
Sulfamethoxazole  +
trimethoprim
1 to  2  trimetoprim  Not
recommended  <  2
months  of  age
Cephalosporin
(ﬁrst
¼ of  therapeutic
dose
Not  recommended
for  prolonged  use
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IUpdate  on  the  approach  of  urinary  tract  infection  
without  recurrent  UTI  (mean  age:  4.8  months).  The  authors
demonstrated  that,  during  the  ﬁrst  year  of  life,  the  earlier
the  ﬁrst  UTI  occurs,  the  higher  the  chance  of  recurrence.
Higher  grades  of  reﬂux,  bilateral  VUR,  and  the  ﬁrst  infection
not  caused  by  E.  coli  signiﬁcantly  increased  the  risk  of
recurrent  UTIs.58
Although  some  prospective  randomized  studies  have
questioned  the  efﬁcacy  of  antibacterial  prophylaxis,  recent
well-designed  trials  have  shown  that  some  subgroup  of
patients  clearly  beneﬁts  from  prophylaxis.27 For  instance,
the  Swedish  reﬂux  study  clearly  demonstrated  that  chemo-
prophylaxis  is  effective  in  preventing  new  renal  scars  in
infant  girls  with  moderate/severe  reﬂux.59,60 Craig  et  al.
have  shown,  in  a  large  placebo-controlled  trial  in  Australia,
that  long-term,  low-dose  trimethoprim--sulfamethoxazole
was  associated  with  a  decreased  number  of  UTI  episodes
in  predisposed  children.55 During  the  study,  36  of  288
patients  (13%)  developed  UTI  in  the  group  receiving
trimethoprim--sulfamethoxazole  (antibiotic  group),  versus
55  of  288  patients  (19%)  in  the  placebo  group  (hazard  ratio
in  the  antibiotic  group,  0.61;  95%  conﬁdence  interval,
0.40--0.93).  In  fact,  the  treatment  effect  appeared  to
be  consistent  across  subgroups,  including  for  younger
children.  The  recently  published  Randomized  Intervention
for  Children  with  Vesicoureteral  Reﬂux  (RIVUR)  trial  with
607  children  (280  with  a  reﬂux  I  or  II  and  322  with  a  reﬂux  III
or  IV)  showed  that  antimicrobial  prophylaxis  with  trimetho-
prim/sulfamethoxazole  reduced  the  risk  of  recurrence  by
50%.61
Good  quality  evidence  for  prophylaxis  in  very  young  chil-
dren  is  limited,  because  there  are  not  speciﬁc  randomized
controlled  trials  for  this  age  group.  Nevertheless,  there
is  a  clear  beneﬁt  of  prophylaxis  for  some  subgroups  and
long-term  low  dose  antibacterial  administration  should  be
considered  in  cases  of  high  susceptibility  to  UTI  and  high  risk
of  acquired  renal  damage.  In  this  context,  the  prophylaxis
should  be  considered  in  the  following  clinical  situations:
(1)  presence  of  prenatal  sonographic  ﬁndings  suggestive  of
uropathies;  (2)  until  the  imaging  investigation  of  the  urinary
tract  has  been  completed;  (3)  in  the  presence  of  severely
dilated  urinary  tract;  (4)  in  the  presence  of  obstructive
uropathy  until  surgical  correction;  and  (4)  in  the  presence
of  VUR  grades  III  to  V.  The  aim  of  prophylaxis  in  these
situations  is  to  prevent  recurrent  UTI  and/or  renal  damage.
Continuous  prophylaxis  with  low-dose  antibiotics  given
for  a  variable  period  time  has  been  the  cornerstone
of  this  approach.27 The  usual  choices  for  prophylaxis
include  trimethoprim-sulfamethoxazole  and  nitrofurantoin
(Table  4).  The  use  of  cephalosporins  for  chemoprophy-
laxis  should  be  considered  during  the  ﬁrst  two  months  of
age,  due  to  possible  side  effects  of  both  trimethoprim-
sulfamethoxazole  and  nitrofurantoin  in  neonates  and  infants
aged  less  than  3  months.  In  spite  of  the  current  contro-
versy  regarding  the  efﬁcacy  of  prophylaxis,  this  approach  is
advisable  for  selected  subgroups  of  patients.  In  these  cases,
prophylaxis  can  protect  from  recurrent  UTI  and  possible
long-term  sequelae.Imaging
Widespread  use  of  prenatal  US  clearly  has  reduced  the
prevalence  of  previously  unsuspected  CAKUT  in  infants.37,62
g
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owever,  the  impact  of  prenatal  screening  on  the  preva-
ence  of  renal  abnormalities  in  infants  with  UTIs  has  not  been
ell  studied  yet.  It  is  important  to  highlight  that  the  qual-
ty  of  prenatal  sonograms  is  extremely  heterogeneous  and
 report  of  ‘‘normal’’  fetal  sonographic  examination  cannot
ule  out  the  possibility  of  structural  abnormalities.37,62
Two  recent  guidelines  on  urinary  tract  infections  in  chil-
ren,  by  the  AAP  and  the  European  Association  of  Urology
EAU),  stated  consensually  that  febrile  infants  with  UTIs
hould  undergo  renal  and  bladder  US  (RBUS).27 The  aim
f  RBUS  is  to  detect  anatomic  abnormalities  that  require
urther  evaluation,  such  as  additional  imaging  or  urologic
rocedure.  RBUS  also  provides  an  evaluation  of  the  renal
arenchyma  and  an  assessment  of  kidneys  size.63 These  fea-
ures  help  establishing  a  tailored  approach  to  monitor  these
atients.  Nevertheless,  some  caution  must  be  taken  in  the
nterpretation  of  ultrasonography  ﬁndings.  The  method  has
ntrinsic  limitations  and  it  is  highly  observer-dependent.  For
nstance,  RBUS  has  low  sensitivity  in  detecting  VUR  and  can-
ot  exclude  the  presence  of  even  high  levels  of  this  uropathy,
lthough  it  may  show  indirect  signs  of  their  presence.64--66
onversely,  renal  US  is  a  very  useful  screening  test  for
bstructive  uropathies  and  other  structural  abnormalities,
s  relatively  inexpensive,  non-invasive,  and  usually  readily
vailable.  As  stated  earlier,  the  timing  of  RBUS  depends
n  the  clinical  status  and  on  the  course  of  treatment.
BUS  is  recommended  early  when  there  is  suspect  of  com-
licated  febrile  UTI  (e.g., renal  abscesses,  pyonephrosis,
nd  structural  abnormalities)  or  in  patients  without  clin-
cal  improvement.  It  must  be  pointed  out,  however,  that
n  acute  renal  parenchyma  infection  may  cause  transitory
lterations,  such  as  urinary  tract  dilatation  and  changes  in
he  echogenicity  of  renal  parenchyma.37
The  AAP  guideline  recommends  that  voiding  cys-
ourethrogram  (VCUG)  should  not  be  performed  routinely
fter  the  ﬁrst  febrile  UTI.  VCUG  is  indicated  if  RBUS  reveals
ydronephrosis,  scarring,  or  other  ﬁndings  that  suggest
ither  high-grade  VUR  or  obstructive  uropathy.37 Conversely,
he  EAU  guideline  recommends  that,  for  infants  under  1
ear,  VUR  should  be  excluded  by  VCUG  and/or  DMSA  scan.
n  addition,  this  guideline  suggests  a  similar  approach  for
irls  above  1  year  of  age,  but  not  for  boys  above  this  age.
or  boys  older  than  1  year,  this  guideline  recommends  only
BUS.  VCUG  should  be  performed  after  the  UTI  has  been
reated.11 Indeed,  two  possible  imaging  strategies  have  been
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28  
ecommended  for  the  diagnosis  of  VUR:  the  bottom-up
ethod  (VCUG  and,  if  positive,  a  DMSA  scan)  or  the  top-down
ethod  (DMSA  scan  and,  if  positive,  VCUG).67,68
Therefore,  currently  there  is  no  consensus  regarding  the
est  imaging  approach  after  the  ﬁrst  episode  of  febrile  UTI.
n  this  context,  Williams  et  al.  suggest  a  simpler  and  direct
pproach:  (1)  renal  tract  sonography  in  all  children,  and  (2)
oiding  cystography  and/or  DMSA  for  children  with  abnormal
enal  tract  sonography.50
oncluding remarks
he  proper  management  of  UTI  is  one  of  the  most  controver-
ial  areas  in  pediatrics.  Nowadays,  the  classiﬁcation  of  a  UTI
s  made  according  to  the  site,  episode,  symptoms,  and  com-
licating  factors.  For  acute  treatment,  the  site  and  severity
re  of  the  most  important  factors.  Treatment  of  patients
ith  febrile  UTIs  should  be  initiated  after  urine  analysis
nd  culture  to  conﬁrm  the  diagnosis.  SPA  and  catheter-
zation  presents  the  lowest  contamination  rate  for  urine
ampling,  while  plastic  bag  remains  the  most  commonly  used
ethod  in  daily  practice.  UTI  can  be  excluded  if  the  dip-
tick  is  negative  for  both  leukocyte  esterase  and  nitrite,
r  if  the  microscopic  analysis  is  negative  for  both  pyuria
nd  bacteriuria.  In  neonates  and  young  infants,  intravenous
ntibiotics  are  usually  recommended  for  the  treatment  of
ebrile  UTI.  The  improvement  of  general  clinical  condition
nd  the  reduction  of  fever  are  indicative  of  good  response  to
reatment  with  antibiotics.  Prophylaxis  has  been  shown  to
e  beneﬁcial  when  prenatal  sonographic  ﬁndings  are  sugges-
ive  of  uropathies,  until  the  imaging  investigation  has  been
ompleted,  in  the  presence  of  severely  dilated  urinary  tract,
f  obstructive  uropathy  (until  surgical  correction),  and  of
esicoureteral  reﬂux  grades  III  to  V.  In  these  situations,
rophylaxis  aims  to  prevent  recurrent  UTI  and/or  renal  dam-
ge.  There  is  still  no  consensus  regarding  the  best  imaging
pproach  after  the  ﬁrst  episode  of  febrile  UTI.  Early  ultra-
onography  of  the  kidney  and  bladder  are  necessary  in  young
atients  with  febrile  UTI  to  exclude  underlying  uropathy.
ongitudinal  prospective  studies  are  still  needed  to  establish
ailored  protocols  for  the  approach  of  UTI  in  childhood.
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